EVOQ Remedies Stock Price Analysis and Quick Research Report. Is EVOQ Remedies an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse EVOQ Remedies. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). EVOQ Remedies has a PE ratio of 102.549575070822 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. EVOQ Remedies has ROA of 1.2609% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. EVOQ Remedies has a Current ratio of 3.1701.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. EVOQ Remedies has a ROE of 1.8088%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. EVOQ Remedies has a Debt to Equity ratio of 0.1679 which means that the company has low proportion of debt in its capital.

• Sales growth: EVOQ Remedies has reported revenue growth of -80.125% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of EVOQ Remedies for the current financial year is -40.4120913016656%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for EVOQ Remedies is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of EVOQ Remedies is Rs 0.0353. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of EVOQ Remedies in Ticker for free. Also, one can get the intrinsic value of EVOQ Remedies by using Valuation Calculators, which are available with a Finology ONE subscription. 

EVOQ Remedies FAQs

Q1. What is EVOQ Remedies share price today?
Ans: The current share price of EVOQ Remedies is Rs 3.62.

Q2. What is the market capitalisation of EVOQ Remedies?
Ans: EVOQ Remedies has a market capitalisation of Rs 9.0138 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of EVOQ Remedies?
Ans: The PE ratio of EVOQ Remedies is 102.549575070822 and the P/B ratio of EVOQ Remedies is 0.202795439903644, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of EVOQ Remedies share?
Ans: The 52-week high share price of EVOQ Remedies is Rs 9.28, and the 52-week low share price of EVOQ Remedies is Rs 2.11.

Q5. Does EVOQ Remedies pay dividends?
Ans: Currently, EVOQ Remedies does not pay dividends. Dividend yield of EVOQ Remedies is around 0%.

Q6. What are the face value and book value of EVOQ Remedies shares?
Ans: The face value of EVOQ Remedies shares is Rs 10, while the book value per share of EVOQ Remedies is around Rs 17.8505. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of EVOQ Remedies?
Ans: EVOQ Remedies has a total debt of Rs 4.2382 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of EVOQ Remedies?
Ans: The ROE of EVOQ Remedies is 1.8088% and ROCE of EVOQ Remedies is 1.9158%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is EVOQ Remedies a good buy for the long term?
Ans: The EVOQ Remedies long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is EVOQ Remedies undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the EVOQ Remedies appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check EVOQ Remedies’s financials?
Ans: You can review EVOQ Remedies’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.